Search results for "ovarian reserve"

showing 4 items of 14 documents

The effect of cancer treatment on female fertility and strategies for preserving fertility.

2006

Aggressive chemotherapy and radiotherapy in young patients with cancer has greatly enhanced the life expectancy of these patients, but these treatments often cause infertility because of the massive destruction of the ovarian reserve resulting in premature ovarian failure (POF). This review focuses on the effect of cancer treatments on fertility and on the various surgical and assisted-reproduction innovations that are available to provide the patient with the option of future pregnancies. As the emerging discipline of fertility preservation is steadily attracting increasing interest, developments in the near future promise to be very exciting. However, in everyday routine work, better inte…

InfertilityAdultmedicine.medical_specialtyReproductive Techniques Assistedmedicine.medical_treatmentmedia_common.quotation_subjectFertilityAntineoplastic AgentsPrimary Ovarian InsufficiencyGonadotropin-Releasing HormoneNeoplasmsmedicineHumansFertility preservationIntensive care medicineOvarian reserveRadiation Injuriesmedia_commonCryopreservationbusiness.industryOvaryObstetrics and GynecologyCancermedicine.diseasePremature ovarian failureSurgeryRadiation therapyFertilityReproductive MedicineLife expectancyOocytesFemalebusinessInfertility FemaleEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

Reproduction beyond cancer: A message of hope for young women

2006

Abstract Objective. Aggressive chemotherapy and radiotherapy or radical oncological surgery in young women with cancer has greatly enhanced these patients' life expectancy, but these treatments often cause infertility or premature ovarian failure due to a massive destruction of the ovarian reserve. The objective of this review is to discuss the effect of the various cancer treatments on fertility and present the various fertility sparing operations and fertility preservation strategies. Method. An extensive survey of the most up-to-date literature was performed. Results. This review discusses the impact of current cancer treatment on fertility potential and the various surgical and assisted…

Infertilitymedicine.medical_specialtyGenital Neoplasms Femalemedia_common.quotation_subjectmedicine.medical_treatmentBreast NeoplasmsFertilitymedicineHumansFertility preservationIntensive care medicineOvarian reservemedia_commonGynecologybusiness.industryObstetrics and GynecologyCancermedicine.diseaseCombined Modality TherapyPremature ovarian failureRadiation therapyFertilityOncologyLife expectancyFemalebusinessInfertility FemaleGynecologic Oncology
researchProduct

Stem cell-secreted factor therapy regenerates the ovarian niche and rescues follicles.

2021

Background Ovarian senescence is a normal age-associated phenomenon, but increasingly younger women are affected by diminished ovarian reserves or premature ovarian insufficiency. There is an urgent need for developing therapies to improve ovarian function in these patients. In this context, previous studies suggest that stem cell–secreted factors could have regenerative properties in the ovaries. Objective This study aimed to test the ability of various human plasma sources, enriched in stem cell–secreted factors, and the mechanisms behind their regenerative properties, to repair ovarian damage and to promote follicular development. Study Design In the first phase, the effects of human pla…

Ovarian CortexOvaryBone Marrow CellsPrimary Ovarian InsufficiencyPremature ovarian insufficiencyHematopoietic Cell Growth Factors03 medical and health sciencesMicePlasma0302 clinical medicineOvarian FollicleMice Inbred NODGranulocyte Colony-Stimulating FactorMedicineAnimalsHumans030212 general & internal medicinePlatelet activationOvarian ReserveStem Cell Factor030219 obstetrics & reproductive medicinebusiness.industryCell growthStem CellsOvaryInfant NewbornObstetrics and GynecologyBone Marrow Stem CellCell cycleFetal BloodDisease Models Animalmedicine.anatomical_structureCancer researchHeterograftsFemaleStem cellbusinessAmerican journal of obstetrics and gynecology
researchProduct

LH administration as a potential strategy for ovarian protection and female fertility preservation against highly gonadotoxic chemotherapy

2022

Els ovaris contenen una reserva de fol·licles no renovable, que produeixen un únic ovòcit fecundable a cada cicle menstrual al llarg de l'etapa reproductiva femenina (15-49 anys), però que disminueix progressivament amb l'edat. Per tant, els factors que afecten negativament la dotació de fol·licles provocaran una reducció significativa de la vida reproductiva en la dona. Les teràpies oncològiques basades en l'administració de quimioteràpia alquilant s'utilitzen habitualment per a tractar els càncers ginecològics en pacients joves, però amb freqüència acceleren l'esgotament de la reserva fol·licular i l'aparició de la menopausa. Els efectes secundaris de la quimioteràpia sobre la fertilitat,…

ovarian reservefertility preservationUNESCO::CIENCIAS MÉDICASluteinizing hormoneUNESCO::CIENCIAS DE LA VIDA::Bioquímicachemotherapyfollicular protection
researchProduct